Other Assets, Noncurrent in USD of Eiger BioPharmaceuticals, Inc. from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and change rate from Q4 2013 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending 31 Dec 2023 was $360K, a 81.1% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $360K -$1.55M -81.1% 31 Dec 2023 10-K 08 Apr 2024
Q3 2023 $144K -$554K -79.4% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $790K -$4.29M -84.4% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $1.07M -$3.84M -78.3% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $1.91M -$2.6M -57.7% 31 Dec 2022 10-K 08 Apr 2024
Q3 2022 $698K -$4.04M -85.3% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $5.08M +$993K +24.3% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $4.91M +$986K +25.1% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $4.51M +$607K +15.6% 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 $4.74M +$959K +25.4% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $4.09M +$304K +8.04% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $3.92M +$140K +3.7% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $3.9M +$1.39M +55.4% 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 $3.78M +$393K +11.6% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $3.78M +$1.18M +45.5% 30 Jun 2020 10-Q 06 Aug 2020
Q1 2020 $3.78M +$1.08M +39.7% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $2.51M +$2.08M +476% 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 $3.39M +$3M +771% 30 Sep 2019 10-Q 07 Nov 2019
Q2 2019 $2.6M +$2.31M +796% 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $2.71M +$2.42M +836% 31 Mar 2019 10-Q 09 May 2019
Q4 2018 $436K +$124K +39.7% 31 Dec 2018 10-K 13 Mar 2020
Q3 2018 $389K +$323K +489% 30 Sep 2018 10-Q 09 Nov 2018
Q2 2018 $290K +$209K +258% 30 Jun 2018 10-Q 10 Aug 2018
Q1 2018 $289K +$165K +133% 31 Mar 2018 10-Q 11 May 2018
Q4 2017 $312K +$169K +118% 31 Dec 2017 10-K 14 Mar 2019
Q3 2017 $66K -$76K -53.5% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 $81K -$64K -44.1% 30 Jun 2017 10-Q 11 Aug 2017
Q1 2017 $124K -$31K -20% 31 Mar 2017 10-Q 12 May 2017
Q4 2016 $143K +$97K +211% 31 Dec 2016 10-K 09 Mar 2018
Q3 2016 $142K +$132K +1320% 30 Sep 2016 10-Q 08 Nov 2016
Q2 2016 $145K +$18K +14.2% 30 Jun 2016 10-Q 10 Aug 2016
Q1 2016 $155K -$30K -16.2% 31 Mar 2016 10-Q 16 May 2016
Q4 2015 $46K -$218K -82.6% 31 Dec 2015 10-K 23 Mar 2017
Q3 2015 $10K -$270K -96.4% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 $127K -$22K -14.8% 30 Jun 2015 10-Q 11 Aug 2015
Q1 2015 $185K +$174K +1582% 31 Mar 2015 10-Q 15 May 2015
Q4 2014 $264K -$2.03M -88.5% 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 $280K 30 Sep 2014 10-Q 12 Nov 2014
Q2 2014 $149K 30 Jun 2014 10-Q 07 Aug 2014
Q1 2014 $11K 31 Mar 2014 10-Q 13 May 2014
Q4 2013 $2.3M 31 Dec 2013 10-K 31 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.